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Abstract
Introduction and Aim
The role of B-lymphocytes in chemical-induced asthma is largely unknown. Recent work
demonstrated that transferring B lymphocytes from toluene diisocyanate (TDI)-sensitized
mice into naïve mice, B cell KO mice and SCID mice, triggered an asthma-like response in
these mice after a subsequent TDI-challenge. We applied two-dimensional difference gel
electrophoresis (2D-DIGE) to describe the “sensitized signature” of B lymphocytes compar-
ing TDI-sensitized mice with control mice.
Results
Sixteen proteins were identified that were significantly up- or down-regulated in B lympho-
cytes of sensitized mice. Particularly differences in the expression of cyclophilin A, cofilin 1
and zinc finger containing CCHC domain protein 11 could be correlated to the function of B
lymphocytes as initiators of T lymphocyte independent asthma-like responses.
Conclusion
This study revealed important alterations in the proteome of sensitized B cells in a mouse
model of chemical-induced asthma, which will have an important impact on the B cell
function.
Introduction
In classic allergic asthma, an important role is attributed to specific IgE antibodies [1,2]. Spe-
cific IgE is produced after isotype class switching of B cells to plasma cells. According to the
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most common paradigm, this response is initiated by antigen presentation to T cells, followed
by T cell activation and secretion of cytokines to activate B lymphocytes. Recently, evidence
has grown that antibody secretion may only be one facet of B cell function. This was first dem-
onstrated by Drolet et al. who showed T cell independent B cell functions [3]. Lindell et al.
showed that pulmonary B cells from mice, chronically challenged with cockroach antigen
(CRA), can present the antigen to CD4+ T cells resulting in Th2 cytokine production in vitro
[4]. In lungs and bronchoalveolar lavage (BAL) fluid of CRA-challenged mice without B cells
(B cell KO), significantly lower levels of Th2 cytokines, IL-4 and IL-5, were detected compared
to wildtype mice (control) and this was accompanied by an attenuation of airway hyperrespon-
siveness (AHR), while inflammatory cells remained present in the lungs of B cell KO mice fol-
lowing chronic CRA challenge compared to control mice.
It is suggested that several low molecular weight (LMW) agents cause occupational asthma
(OA) by an IgE-independent mechanism. For example, in workers with toluene-2,4-diisocya-
nate (TDI)-induced OA, specific IgE is detected in only 0–40% of the workers [5–7]. This
implies that, if the function of B lymphocytes would be limited to the secretion of IgE antibod-
ies, they would not play a major role in chemical-induced OA. Yet, consistent increases in
CD19+ B lymphocytes are observed in models of chemical-induced asthma [8–12].
Recently, De Vooght et al. transferred CD19+ B lymphocytes from TDI sensitized mice into
naïve mice. Three days later, these mice exhibited AHR and a neutrophilic lung inflammation
after a single TDI-challenge. Moreover, transferring CD19+ B lymphocytes from TDI-sensi-
tized wild type mice into B cell KO mice or SCID (severe combined immunodeficiency) mice
also resulted in AHR and neutrophilic lung inflammation after a single TDI-challenge, suggest-
ing a potential role for B lymphocytes without the need or even presence of T lymphocytes
[13]. Furthermore, B lymphocytes from TDI-sensitized mice expressed surface markers such as
MHC II, and co-stimulatory molecules, confirming the results of Lindell et al., and implying a
potential role of antigen presentation for B cells [4]. So, B lymphocytes from sensitized mice
appear to carry a ‘sensitization signature’, which allows them to generate an asthma-like
response after a specific allergen challenge in naïve mice who received an adoptive transfer of B
lymphocytes from sensitized mice.
We compared the proteome of auricular CD19+ B lymphocytes from TDI-sensitized versus
control mice, in order to identify a possible ‘sensitization signature’.
Materials and Methods
All experiments were performed with approval of the KU Leuven Ethical Committee on animal
experiments (project number: 066/2011).
Reagents
Toluene-2,4-diisocyanate (TDI) (98%; Fluka, CAS 584-84-9) and acetone were obtained from
Sigma-Aldrich (Bornem, Belgium). Pentobarbital (Nembutal
1
) was obtained from Sanofi
Santé Animale (CEVA, Brussels, Belgium). The vehicle (acetone/olive oil, AOO) used to dis-
solve TDI consisted of a mixture of 2 volumes of acetone and 3 volumes of olive oil (Selection
de Almazara, Carbonell, Madrid, Spain). Concentrations of TDI are given as percent (v/v) in
AOO.
Animals
Male BALB/c mice were obtained from Harlan (Horst, The Netherlands) and were kept in a
conventional animal house in filter top cages with a 12h light/dark cycle and had access to
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lightly acidified water and food (Trouw Nutrition, Ghent, Belgium) ad libitum. All mice were 6
weeks old and approximately 20 g.
Mouse model and cell isolation
On days 1 and 8, mice received dermal applications of 0.3% TDI or vehicle (AOO, control) on
the dorsum of both ears (20 μl/ear). On day 15, these mice were sacrificed and auricular lymph
nodes were collected and pooled.
Cell suspensions were obtained by pushing the lymph nodes through a cell strainer
(100 μm) and rinsing them with 10 ml buffer (MACS BSA Stock solution diluted 1:20 with
autoMACS Rinsing Solution (Miltenyi Biotec, Utrecht, The Netherlands). Following centrifu-
gation (1000 g, 4°C, 10 min) cells were counted using a Bürker hemocytometer. CD19+ B-lym-
phocytes were isolated with CD19+ microbeads (Miltenyi Biotec, Utrecht, The Netherlands)
according to manufacturer’s instructions.
Sample preparation for 2D-DIGE
Isolated B-lymphocytes were homogenized in 200 μl of lysis buffer with protease inhibitor
using a cone sonicatior (3 x 10 s with 30 s on ice in between). Following centrifugation (1000 g,
4°C, 10 min), supernatants of isolated CD19+ B lymphocytes were removed and 200μl of lysis
buffer (40 mM Tris base, pH 8.8, 7 M urea, 2 M thiourea, 4% CHAPS and 1% dithiothreitol)
with protease inhibitor (40 μl of ¼ tablet Complete in 500 μl MilliQ water, per ml lysis buffer)
were added. Samples were sonicated and centrifuged (13000 g, 4°C, 10 min) after which super-
natants were collected. To concentrate samples, ultramembrane centrifugation with Amicon
Ultra10k (cut-off 10 kDa, Merck Millipore, Darmstadt, Germany) was performed according to
manufacturer’s instructions.
Prior to labelling, pH of all samples was adjusted (between pH 8–9), if necessary, by adding
small amounts of lysis buffer (pH = 8.35). Afterwards samples were desalted via dialysis (Mini
Dialysis kit 1 kDa cut-off, GE Healthcare, Freiburg, Germany) and concentrations were mea-
sured using the Bradford method.
2D-DIGE analysis and protein identification
Six biological replicates of pooled CD19+ B lymphocytes extracted from auricular lymph nodes
of TDI-sensitized mice (n = 3) were compared with six biological replicates of pooled CD19+ B
lymphocytes of control mice (n = 5) after CyDye DIGE Fluor minimal labelling (GE Health-
care) according to manufacturer’s instructions. A two-dimensional gel electrophoresis separa-
tion was carried out as previously described [14]. Gels were scanned with the Ettan DIGE
Imager according to manufacturer’s instructions and digital images were analysed with Decy-
der 2D Differential Analysis 7.0 software (GE Healthcare).
Principal component analysis (PCA) was performed in the Extended Data Analysis module.
PCA is a mathematical procedure that converts a set of variables (here proteome maps) into a
new coordinate system such that the greatest variance is depicted on the first coordinate (called
the first component or PC1), the second greatest variance on the second coordinate (PC2), and
so on. So, if proteome maps of B cells from TDI-sensitized versus non-sensitized mice are suffi-
ciently different, they should be clearly separated by projection on PC1. In other words, a PC1
value equal to 80% implies that 80% of the variance present in the dataset is explained by PC1
(e.g. control vs. TDI).
Spots of interest were manually excised under a laminar flow hood from silver stained pre-
parative gels containing 150 μg of protein. Removal of silver and trypsin digestion were per-
formed as previously described [14]. Tryptic digests were redissolved in 50 μl of 2%
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acetonitrile/0.1% aqueous trifluoroacetic acid and concentrated and desalted using Millipore
ZiptipsC18 (15 μm), according to manufacturer’s instructions. Elution was done with 4.5 μl of
70% acetonitrile/0.1% formic acid. 1 μl was then spotted together with 1 μl of a saturated solu-
tion of α-cyano-4-hydroxy-cinnamic acid (matrix) in acetone on a MALDI target plate.
Peptide mass fingerprinting was performed on a matrix-assisted laser desorption ionisation
tandem time-of-flight (MALDI-TOFTOF) mass spectrometer in positive ion reflectron mode
(Ultraflex II, Bruker Daltonics, Bremen, Germany).
Protein database (NCBInr database or SwissProt—Mus musculus taxonomy) searching was
performed with peptide mass fingerprinting on an ‘in-house’Mascot server (Matrix Science,
London, UK). Trypsin was selected as an enzyme, peptide tolerance was set to 0.2 Da, one
missed cleavage per peptide was allowed, carbamidomethylation of cysteine, as a result of the
equilibration with iodoacetamide, was set as a fixed modification and methionine oxidation
was set as variable modification. The probability-based MOWSE (Molecular Weight Search)
scores greater than the given cut-off value were considered as significant (p< 0.05).
The identified proteins were classified according to their biological function retrieved from
Gene Ontology.
Verification of differentially expressed proteins
Two of the identified immune-related proteins, Cyclophilin A (CypA) and Cofilin 1 (Cof1),
that were included in the list of proteins contributing to the separation of the TDI-treated
group and AOO-treated group in the PCA were verified via Western blotting in B lymphocytes
obtained from a new, independent set of similarly treated TDI- and AOO-treated mice
(n = 10/group). Briefly, proteins were loaded and separated on 4–12% Bis/Tris Midi-gels (Invi-
trogen, Merelbeke, Belgium) and subsequently transferred to a PVDF membrane (iBlot, Gel
Transfer Stack, Invitrogen). Membranes were blocked (1–2 h, 5% blocking agent, GE Health-
care) and incubated overnight with primary antibody (LSP-1: 1/1000, goat Ab, Santa Cruz Bio-
technology; CypA: 1/1000, mouse Ab, Santa Cruz Biotechnology; GAPDH, internal standard,
1/200000, mouse Ab, Dako). Following secondary Ab incubation (LSP-1: 1/50000, donkey
anti-goat IgG, Santa Cruz Biotechnology; Cof1 and GAPDH: 1/100000, goat anti mouse IgG,
Dako) protein bands were visualized using chemiluminescence detection (Supersignal West
Dura, Thermo Scientific) on ECL hyperfilm (GE Healthcare). The protein bands were semi-
quantitatively evaluated by densitometry (ImageQuant TL v2009, GE Healthcare).
Statistical analysis
Graphpad Prism 5.01 (Graphpad Software Inc) was used for statistical analysis of theWestern blot
data. All data were normally distributed (tested using Kolmogorov-Smirnov). An unpaired t-test
was used to compare both groups (AOO vs. TDI). A level of p<0.05 was considered significant.
Results
2D-DIGE analysis and protein identifications
The proteomes of six CD19+ B lymphocyte extracts obtained from pooled auricular lymph
nodes from TDI-sensitized mice were compared with the proteomes of six CD19+ B lympho-
cyte extracts obtained from AOO-treated control mice via 2D-DIGE. Proteome analysis
revealed 38 differentially expressed proteins (p<0.01), of which 15 proteins were upregulated
and 23 were downregulated in B lymphocytes from TDI-sensitized mice. Principal component
analysis (PCA; Fig 1A) separated both the TDI and AOO proteome maps based on the differ-
entially expressed proteins (p<0.01). Only one TDI proteome map was not clearly separated.
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Fig 1. Principal component analysis (PCA). PCA of the proteomemaps of sensitized and non-sensitized
CD19+ B lymphocytes. (A) PCA of all six biological replicates. (B) PCA of five biological replicates. Green
dots correspond to AOO-treated mice (controls; n = 5/group). Red dots correspond to TDI-sensitized mice
(n = 3/group).
doi:10.1371/journal.pone.0138791.g001
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PC1 and PC2 values were equal to 74.7% and 12.7% respectively. Removing the gel that con-
tained the ‘aberrant’ TDI proteome map from the analysis, resulted in a complete separation of
both groups, with PC1 and PC2 values equal to 84% and 8.6% respectively (Fig 1B).
Using, peptide mass fingerprinting 16 differentially expressed proteins were identified (Table 1,
Fig 2, S1–S15 Figs). The identified proteins were grouped in classes according to their biological
function retrieved from Gene Ontology (www.geneontology.org, Fig 3). Proteins were classified as
structural proteins (25%), proteins involved in metabolism (19%), protein synthesis (13%) or bind-
ing proteins (12%). One protein, zinc finger CCHC domain containing protein 11, is involved in
immunity. The remaining proteins were involved in other biological functions (25%).
Western blot verification
We verified two of the differentially expressed proteins resulting from the 2D-DIGE analysis
via Western blotting in an independent group of TDI-treated and AOO-treated mice. We
Table 1. Differentially expressed proteins in CD19+ B cells from TDI-sensitized versus non-sensitized mice (p<0.01).
Gene Ontology
Spot no.
Name No. of
Spots
Accession
ID
Score Seq Cov
(%)
Peptides
matched
Fold
Change
pI* Mw
(Da)*
Structural
1977 cofilin 1 1 P18760 76 65 12 1.9834 8.22 18776
873 dynamin 1 1 P39053 66 18 14 -1.8080 6.57 98140
993 beta actin 1 P60710 70 38 12 -1.8503 5.23 42053
979 nebulin-related-anchoring protein
(N-RAP)
1 Q80XB4 70 30 35 -2.1183 9.27 133899
Metabolism
1471 alcohol dehydrogenase [NADP+] 1 Q9JII6 75 33 13 2.2563 6.90 36792
934–949 alpha-enolase 2 P17182 166 50 24 1.6560 6.37 47453
1281 dTDP-D-glucose
4,6-dehydratase
1 Q8VDR7 56 24 11 -1.8157 5.92 40857
Immune response
558 zinc finger CCHC domain
containing protein 11
1 B2RX14 81 26 25 -2.1068 6.72 114480
Binding
973 vinculin 1 Q64727 55 26 26 -1.8792 5.77 117215
523-973-979 centromere protein C 1
(CENP-C)
3 P49452 57 29 27 -2.1183 9.71 102676
Protein synthesis
2049–2062 cyclophilin A 2 P17742 96 64 15 2.8536 7.74 18131
984 elongation factor Tu 1 Q8BFR5 114 61 23 1.5235 8.59 50240
Other
1626 rho GDP dissociation inhibitor
(GDI) beta
1 Q61599 70 59 10 2.6210 4.97 22894
2013 proteasome 26S subunit 1 P46471 78 24 16 2.4681 5.25 40580
1522 sterile alpha motif domain-
containing protein 14
1 Q8K070 67 26 10 2.1569 9.51 45075
1605 rho GDP dissociation inhibitor
(GDI) alpha
1 Q99PT1 98 47 14 1.8416 5.20 22991
Proteins are ranked according ontology, followed by most upregulated to most downregulated. Individual mass spectra can be found in S1 to S15 Figs.
* pI and Mw are depicted as theoretical values.
doi:10.1371/journal.pone.0138791.t001
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Fig 2. Representation of the identified differentially expressed proteins on a raw 2D-DIGE gel image.
doi:10.1371/journal.pone.0138791.g002
Fig 3. Classification of the identified differentially expressed proteins. The differentially expressed
proteins in CD19+ B lymphocytes from sensitized versus non-sensitized mice were classified according to
biological function (retrieved from Gene Ontology).
doi:10.1371/journal.pone.0138791.g003
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selected cyclophilin A (CypA) and cofilin 1 (Cof1) for verification based on two criteria: (1)
biologically relevance in the process of sensitization and (2) contribution to the discrimination
between TDI- and AOO-treatment in the principal component analysis (PCA). Western blot-
ting confirmed the significant up-regulated expression of both CypA and Cof1 in B lympho-
cytes of TDI-sensitized mice (Fig 4A and 4B).
Fig 4. Validation of differentially expressed proteins usingWestern blotting. (A) Cyclophilin A (CypA)
and (B) Cofilin 1 (Cof1) validation in CD19+ B lymphocytes usingWestern blotting. Validation experiments
were performed in a separate set of mice. Figure shows individual mice and group means. n = 10; **p<0.01,
***p<0.001.
doi:10.1371/journal.pone.0138791.g004
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Discussion
In this study, we applied a proteomics approach to compare the proteomes of isolated sensi-
tized and non-sensitized CD19+ B lymphocytes in a well-established and characterized mouse
model of chemical-induced asthma [9,14–19]. In previous isolation experiments, the purity of
the isolated CD19+ B lymphocytes was verified several times via FACS. The combined impurity
(T cells, dendritic cells, . . .) was always less than 5% and, therefore, it was not checked in this
study [13]. Using 2D-DIGE, we found significant differences in the respective proteomes, with
the identification of several proteins that can be linked to the onset of chemical-induced
asthma.
An important role has long been reserved for T lymphocytes and the cytokines they produce
in the development of allergic asthma and OA, whereas the role of B lymphocytes in allergic
asthma or OA was thought to be restricted to the production of antibodies. Since, several
LMW agents (e.g. diisocyanates and persulfate salts) causing OA probably do not act via spe-
cific IgE antibodies, it might at first site suggest that B lymphocytes are merely bystanders. Yet,
recent studies have rejuvenated the interest in the role of B lymphocytes. In a mouse model of
cockroach-induced asthma, Lindell et al. showed that B lymphocytes can act as antigen pre-
senting cells (APC), presenting antigen to naïve T lymphocytes [20]. Our research group also
confirmed an increased MHCII expression on the surface of B lymphocytes of TDI-sensitized
mice [13]. Moreover, allergen-induced AHR was significantly attenuated in B cell KO mice
compared to control mice [4]. In our mouse model of chemical-induced asthma, similar effects
were seen. Naïve wild type, B cell KO or SCID mice, that received CD19+ B lymphocytes from
TDI-sensitized mice were challenged three days later with TDI, resulting in AHR and a neutro-
philic lung inflammation [13]. The observed time course (three days) points against a process
depending on IgE production by mature plasma cells. Moreover, the glycoprotein CD19 is only
expressed on the surface of early pre-B lymphocytes and not on IgE producing plasma cells;
consequently no immunoglobulin producing cells were transferred, thus again supporting anti-
body-independent functions for B lymphocytes [21]. So far, it remains unknown which fea-
tures differentiate sensitized from non-sensitized B lymphocytes.
Our 2D-DIGE study shows significant differences in the proteome of B lymphocytes from
TDI-sensitized mice compared with non-sensitized mice. In fact PCA can discriminate TDI-
sensitized from non-sensitized mice based on their proteome maps. PCA highlighted one aber-
rant proteome map among the TDI-group (Fig 1), most likely resulting from a technical issue
(e.g. imperfect CyDye labeling) and not as a result of treatment, as lymphocytes of auricular
lymph nodes from three animals were pooled. Excluding the gel containing this proteome map
from the PCA analysis resulted in an even stronger discrimination of the two groups
(PC1 = 84%, PC2 = 8.6%).
We found a nearly three-fold upregulation of cyclophilin A (CypA) in B lymphocytes of
TDI-sensitized mice, which we confirmed in an independent Western Blot experiment. CypA
is a member of the cyclophilins, a family of intracellular proteins found in all organisms and in
all human tissues. In humans, they are mainly secreted in response to inflammatory stimuli
such as LPS or reactive oxygen radicals [22,23]. CypA is a potent chemoattractant for mono-
cytes, neutrophils, eosinophils and T lymphocytes. High levels of CypA were found in the
lungs of mice with ongoing pulmonary neutrophilia induced by LPS [24]. In rheumatoid
arthritis patients, a direct correlation was described between levels of CypA and the number of
neutrophils in the synovial fluid [25]. Stemmy et al. showed that blocking the function of CypA
in chronic allergic asthma decreased the number of persisting leukocytes drastically, accompa-
nied by a significant reduction in AHR to methacholine [26]. Recently, we also showed that
transfer of B lymphocytes from sensitized mice into naïve mice can lead to a neutrophilic lung
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inflammation after challenge [13]. We speculate on a possible role for CypA in the recruitment
of neutrophils to the lungs of TDI-treated mice. Macrophage inflammatory protein 2 (MIP-2),
the mouse analogue of the human pro-inflammatory cytokine IL-8, is a potent neutrophil che-
moattractant. Together with CypA, MIP-2 was demonstrated to have a synergistic effect on
neutrophil migration [27]. In humans, CypA induces the secretion of the pro-inflammatory
cytokine IL-8. In mice, augmented levels of MIP-2 are found in the BAL fluid of TDI-asthmatic
mice, suggesting a similar effect [9].
Cofilin 1 (Cof1), nearly 2-fold upregulated in B lymphocytes from TDI-sensitized mice,
belongs to a family of actin-binding proteins and is ubiquitously expressed in all eukaryotic cell
types. Cof1 is able to promote rearrangements in the actin cytoskeleton. T lymphocytes need a
dynamic cytoskeleton to exert their function in the adaptive immune system, namely patrolling
the body in the search for pathogen-derived peptides presented by antigen presenting cells
[28,29]. To this end, the round shape of a T lymphocyte converts towards a more flattened
shape, enabling T lymphocytes to crawl over APCs screening for antigens. Once a specific anti-
gen is recognized, T lymphocytes further adjust their morphology, building up a close contact
zone to finally become activated [29]. Here we found an upregulation of Cof1 in CD19+ B lym-
phocytes of TDI-sensitized mice. Recently, the antigen presenting functions for B lymphocytes
have been rediscovered [4]. The upregulation of Cof1 is an indirect indication of the possible
antigen presenting capacities of B lymphocytes, for which dynamic actin cytoskeleton rear-
rangements are required.
Zinc finger CCHC domain containing protein 11 (ZCCHC11) was two-fold down regulated
in TDI-sensitized B lymphocytes. Jones et al showed that ZCCHC11 fine tunes IL-6 production
by uridylating miRNA’s [30], while Minoda et al, proposed that ZCCHC11 could be a unique
TLR signal regulator, able to suppress activation of NF-κB [31]. The activation of the NF-κB
pathway is believed to be sufficient to induce B lymphocyte-induced maturation protein-1
(Blimp-1 expression), a transcription factor crucial for the development of immunoglobulin-
secreting cells. Although the role of IgE in chemical-induced asthma remains a lingering ques-
tion, in previous work in mice, we found significant increases in total serum IgE levels, of
which we here possibly demonstrate an early signal at the protein level, i.e. preparing CD19+ B
lymphocytes to switch to plasma cells [9,18,32].
In conclusion, we have demonstrated significant proteomic alterations in CD19+ B lympho-
cytes from TDI-sensitized mice compared to control mice. Differences in the expression of
CypA, Cof1 and ZCCHC11 can be directly correlated to functions of B lymphocytes in the pro-
cess of sensitization and a subsequent asthmatic response. Further studies to functionally vali-
date these results are encouraged.
Supporting Information
S1 Fig. protein 558: mass spectrum of protein zinc finger CCHC domain containing pro-
tein 11.
(TIF)
S2 Fig. protein 873: mass spectrum of protein dynamin 1.
(TIF)
S3 Fig. protein 949: mass spectrum of protein alpha-enolase.
(TIF)
S4 Fig. protein 973: mass spectrum of protein vinculin.
(TIF)
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S5 Fig. protein 979a: mass spectrum of protein nebulin-related-anchoring protein
(N-RAP).
(TIF)
S6 Fig. protein 984: mass spectrum of protein elongation factor Tu.
(TIF)
S7 Fig. protein 993: mass spectrum of protein beta actin.
(TIF)
S8 Fig. protein 1281: mass spectrum of protein dTDP-D-glucose 4,6-dehydratase.
(TIF)
S9 Fig. protein 1471: mass spectrum of protein alcohol dehydrogenase [NADP+].
(TIF)
S10 Fig. protein 1522: mass spectrum of protein sterile alpha motif domain-containing
protein 14.
(TIF)
S11 Fig. protein 1605: mass spectrum of protein rho GDP dissociation inhibitor (GDI)
alpha.
(TIF)
S12 Fig. protein 1626: mass spectrum of protein rho GDP dissociation inhibitor (GDI)
beta.
(TIF)
S13 Fig. protein 1977: mass spectrum of protein cofilin 1.
(TIF)
S14 Fig. protein 2013: mass spectrum of protein proteasome 26S subunit.
(TIF)
S15 Fig. protein 2049: mass spectrum of protein cyclophilin A.
(TIF)
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